SSRI
SSRI is a pharmaceutical drug with 22 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.1%
16 of 17 finished
5.9%
1 ended early
2
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER
A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Stepped Care AiTBS 2 Depression Study (Ghent)
Non-invasive BCI and Application Verification for Depressed People
Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
Clinical Trials (22)
MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER
A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Stepped Care AiTBS 2 Depression Study (Ghent)
Non-invasive BCI and Application Verification for Depressed People
Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder
SSRI's and the Rate of Progression From MCI to Dementia
Intradermal Acupuncture Versus Sham Acupuncture and SSRI for Treating Adolescents With Major Depressive Disorder
Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression
A Study of LY2216684 in Participants With Major Depression Disorder
Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
A Study in Prevention of Re-emergence of Depression Symptoms
A Safety Study in Participants With Major Depressive Disorder
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)
Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder
Enhanced Motor Recovery Using Serotonergic Agents in Stroke
CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 22